Found 120 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma NA In this prospective study, 68Ga-PSMA integrated PET/MR imaging was applied ...
Show More Location
China, Hubei Province
Learn More & Join Trial
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) PHASE2 In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan PHASE2 The purpose of this study is to assess the efficacy, tolerability, safety, ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer PHASE1 This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
18F-DCFBC PET/CT in Prostate Cancer EARLY_PHASE1 Background:
\- Prostate cancer is the second leading cause of cancer death...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer PHASE3 This phase III study provides access to 68Ga-PSMA-11 positron emission tomo...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer PHASE2 This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer NA The purpose of this study is to determine the pharmacokinetics, dosimetry, ...
Show More Location
68Ga-PSMA-33 PET/CT imaging
Learn More & Join Trial
Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas NA As a part of molecular imaging, many PET tracers have been investigated in ...
Show More Location
All India Institute of Medical Sciences, Bhubaneswar
Learn More & Join Trial